Oral locally active steroids in inflammatory bowel disease

Su2080 Efficacy of Budesonide MMx(r) 6 mg QD for the Maintenance of Remission in Patients With Ulcerative Colitis: Results From a Phase III, 12 Month Safety and Extended use Study

(2015) William J. Sandborn et al.   GASTROENTEROLOGY

1158 Double-Blind, Double-Dummy, Randomized, Placebo-Controlled, Multicenter Trial of Budesonide and Mesalamine in Collagenous Colitis

(2015) Stephan Miehlke et al.   GASTROENTEROLOGY

Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab

(2012) Manuel Barreiro-de Acosta et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Acute and chronic pouchitis—pathogenesis, diagnosis and treatment

(2012) Bo Shen   Nature Reviews Gastroenterology & Hepatology

Beclomethasone dipropionate: A second chance for topical steroids as maintenance therapy in ileal Crohn's disease

(2011) Vincent Billioud et al.   DIGESTIVE AND LIVER DISEASE

Beclomethasone dipropionate in Crohn's ileitis: A randomised, double-blind trial

(2011) Cosimo Prantera et al.   DIGESTIVE AND LIVER DISEASE

Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: A multicenter study

(2011) Barreiro-de M. Acosta et al.   INFLAMMATORY BOWEL DISEASES

Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease

(2010) Andreas Tromm et al.   GASTROENTEROLOGY

Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: The RECLICU Study

(2010) Tiago Nunes et al.   Journal of Crohns & Colitis

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

(2010) A. Dignass et al.   Journal of Crohns & Colitis

3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial

(2010) Volker Gross et al.   Journal of Crohns & Colitis

Oral Beclomethasone Dipropionate as an Alternative to Systemic Steroids in Mild to Moderate Ulcerative Colitis Not Responding to Aminosalicylates

(2009) Claudio Papi et al.   DIGESTIVE DISEASES AND SCIENCES

Budesonide Is Effective in Treating Lymphocytic Colitis: A Randomized Double-Blind Placebo-Controlled Study

(2009) Stephan Miehlke et al.   GASTROENTEROLOGY

Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohnʼs disease: A randomized placebo-controlled trial

(2009) Arie Levine et al.   INFLAMMATORY BOWEL DISEASES

Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9mg extended-release tablets in patients with active left-sided ulcerative colitis

(2009) G.R. D'Haens et al.   Journal of Crohns & Colitis

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

(2009) Gert Van Assche et al.   Journal of Crohns & Colitis

Budesonida oral en el tratamiento de la reservoritis crónica refractaria

(2008) José Luis Cabriada Nuño et al.   Gastroenterologia y Hepatologia

After budesonide, what next for collagenous colitis?

(2008) D. S Pardi   GUT

Budesonide induction and maintenance therapy for Crohnʼs disease during pregnancy

(2008) Dawn B. Beaulieu et al.   INFLAMMATORY BOWEL DISEASES

European evidence-based Consensus on the management of ulcerative colitis: Current management

(2008) S.P.L. Travis et al.   Journal of Crohns & Colitis